ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ADAP Adaptimmune Therapeutics PLC

1.04
-0.01 (-0.95%)
29 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 388.27M332.2M328.92M288.08M342.98M296.64M282.62M258.01M
Total Current Assets 321.17M264.14M255.37M213.75M261.77M219.37M207.55M186.9M
Cash and Equivalents 97.81M79M108.03M119.87M76.97M90.06M143.99M140.67M
Total Non-Current Assets 112.51M116.24M55.53M110.75M136.71M129.84M105.25M99.96M
Total Liabilities 246.35M218.87M247.04M204.21M216.33M208.51M243.1M233.64M
Total Current Liabilities 73.63M66.08M64.5M63.63M76.13M75.15M72.79M66.41M
Total Non-Current Liabilities 172.72M152.79M182.54M140.57M140.21M133.36M170.32M167.22M
Common Equity 1.39M1.39M1.4M1.41M1.85M1.86M1.87M2.08M
Retained Earnings -838.63M-880.05M-909.3M-908.27M-929.66M-975.26M-1.02B-1.07B
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 239.14M287.21M282.95M181.54M451.14M469.55M328.92M282.62M
Total Current Assets 198.75M230.18M231.1M120.49M398.15M415.46M255.37M207.55M
Cash and Equivalents 158.78M84.04M68.38M50.41M56.88M149.95M108.03M143.99M
Total Non-Current Assets 170.77M209.05M253.1M123.64M341.23M205.96M81.88M39.51M
Total Liabilities 68.37M78.16M29.85M57.91M109.92M263.59M247.04M243.1M
Total Current Liabilities 40.27M74.31M24.44M34.34M39.07M62.54M64.5M72.79M
Total Non-Current Liabilities 28.1M3.85M5.41M46.53M70.84M201.04M182.54M170.32M
Total Equity 170.77M209.05M253.1M123.64M341.23M205.96M81.88M39.51M
Common Equity 683k854k939k943k1.33M1.34M1.4M1.87M
Retained Earnings -114.81M-176.76M-243.72M-455.66M-585.76M-743.85M-909.3M-1.02B